Denis Weber
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
-
- Advanced Breast Cancer Therapies
Papers in
-
- Advanced Breast Cancer Therapies 4
-
- PI3K/AKT/mTOR signaling in cancer 3
- Co-authors
- Angelo Di Leo (3 shared papers)Thomas Decker (2 shared papers)Ruth O’Regan (2 shared papers)Eva Ciruelos (2 shared papers)Dalila Sellami (1 shared paper)Tibor Csőszi (2 shared papers)Dimitar Kalev (1 shared paper)Daniel Egle (1 shared paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Denis Weber
5 papers receiving 50 citations
Peers
Comparison fields: 5 of 11
- Oncology 28
- Pulmonary and Respiratory Medicine 31
- Genetics 8
- Cancer Research 11
- Molecular Biology 16
Countries citing papers authored by Denis Weber
This map shows the geographic impact of Denis Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Weber more than expected).
Fields of papers citing papers by Denis Weber
This network shows the impact of papers produced by Denis Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Weber. The network helps show where Denis Weber may publish in the future.
Co-authors
The 25 scholars most cited alongside Denis Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 38 | |
| 2 | BELLE-3: A Phase III study of the pan-phosphatidylinositol 3-kinase (PI3K) inhibitor buparlisib (BKM120) with fulvestrant in postmenopausal women with HR+/HER2- locally advanced/metastatic breast cancer (BC) pretreated with aromatase inhibitors (AIs) and refractory to mTOR inhibitor (mTORi)-based treatment. | 2015 | 5 |
| 3 | 2012 | 3 | |
| 4 | 2012 | 2 | |
| 5 | 2011 | 2 |
About Denis Weber
Denis Weber is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Genetics and Genetics, having authored 5 papers that have together received 50 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and BRCA gene mutations in cancer (1 paper). The work is most often cited by research in Oncology (28 citations), Pulmonary and Respiratory Medicine (31 citations), Genetics (8 citations), Cancer Research (11 citations) and Molecular Biology (16 citations). Denis Weber has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Angelo Di Leo, Thomas Decker, Ruth O’Regan, Eva Ciruelos, Dalila Sellami, Tibor Csőszi, Dimitar Kalev, Daniel Egle, Thomas Bachelot and Roberto Bordonaro. Their work appears in journals such as Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.